BrainsWay Ltd. (BWAY)
BrainsWay Ltd.
Bynet Building
3rd Floor 19 Hartum Street Har Hotzvim
Jerusalem 9777518
Israel
972-2-582-4030
https://www.brainsway.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 134
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Hadar Levy | Chief Executive Officer | 434k | N/D | 1974 |
| Mr. Avner Hagai | Founder & Director | 43.65k | N/D | 1956 |
| Prof. Abraham Zangen | Co-Founder, Member of Scientific Advisory Board & Director | 72.17k | N/D | 1970 |
| Dr. Yiftach Roth Ph.D. | Founder & Chief Scientific Officer | 108k | N/D | 1971 |
| Mr. Ido Marom | Chief Financial Officer | N/D | N/D | 1976 |
| Mr. Menachem C. Klein Esq. | VP, General Counsel & Corporate Secretary | N/D | N/D | N/D |
| Dr. Aron Tendler | Chief Medical Officer | N/D | N/D | N/D |
Descripción
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Gestión corporativa
La calificación ISS Governance QuickScore de BrainsWay Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
